4-(Bromomethyl)-1H-indazole hydrobromide

Catalog No.: 
ACLYZJ521
CAS No.: 
264276-18-8
Molecular Formula: 
C8H8Br2N2
Molecular Weight: 
291.97
4-(Bromomethyl)-1H-indazole hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$125.00In stockInquiry
5g95%$613.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Bromomethyl)-1H-indazole hydrobromide
IUPAC Name4-(bromomethyl)-1H-indazole hydrobromide
MDL No.MFCD27923778
Molecular FormulaC8H8Br2N2
Molecular Weight291.97
SMILESBrCC1=CC=CC2=C1C=NN2.[H]Br
InChI KeyNXPNEYAWBKBBMP-UHFFFAOYSA-N
Synonym4-(BroMoMethyl)-1H-indazole hydrobroMide;1H-Indazole, 4-(bromomethyl)-, hydrobromide (1:1)
CAS No.264276-18-8
PubChem CID22661307

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLYZJ521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMJHP560 route compound structure diagram
    ACMJHP5603176-63-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLYZJ521 route product structure diagram
    ACLYZJ521264276-18-8In Stock
Inquiry

2. ACLYZJ521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXAHT378 route compound structure diagram
    ACXAHT378709608-85-5In Stock
  4. Then
  5. ACLYZJ521 route product structure diagram
    ACLYZJ521264276-18-8In Stock
Inquiry

3. ACLYZJ521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLYZJ521 route product structure diagram
    ACLYZJ521264276-18-8In Stock
Inquiry

Comments (0)